Get the Stockscreener App
48.69
4.23%
-2.15
Pre-market:
47.21
-1.48
-3.04%
Tempus Ai Inc stock is traded at $48.69, with a volume of 4.62M.
It is down -4.23% in the last 24 hours and down -13.30% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$50.84
Open:
$50.15
24h Volume:
4.62M
Relative Volume:
0.89
Market Cap:
$8.70B
Revenue:
$1.27B
Net Income/Loss:
$-245.03M
P/E Ratio:
-34.60
EPS:
-1.4071
Net Cash Flow:
$-245.36M
1W Performance:
-7.57%
1M Performance:
-13.30%
6M Performance:
-44.08%
1Y Performance:
+6.45%
1-Day Range:
$48.63
$50.58
1-Week Range:
$48.63
$52.67
52-Week Range:
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
48.69 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
VEEV
Veeva Systems Inc
|
184.03 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
BTSG
Brightspring Health Services Inc
|
43.07 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
79.57 | 6.80B | 1.29B | 191.83M | 362.67M | 2.182 |
|
WAY
Waystar Holding Corp
|
24.65 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
3 MedTech stocks poised to gain in 2026 from the AI boom - MSN
Tempus AI Pediatric Leukemia Registry Deepens Oncology Data And Patient Reach - Yahoo Finance Singapore
Top Artificial Intelligence Stocks To ResearchMarch 18th - MarketBeat
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Weakness? - Yahoo Finance
Promising Artificial Intelligence Stocks To Keep An Eye OnMarch 17th - MarketBeat
Is Tempus AI (TEM) The Best AI Healthcare Stock in Cathie Wood’s Portfolio? - Insider Monkey
Tempus and Blood Cancer United announce collaboration to develop one of the largest pediatric acute myeloid leukemia Real-World Data registries - marketscreener.com
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries - The AI Journal
Best Artificial Intelligence Stocks To Add to Your WatchlistMarch 16th - MarketBeat
Tempus AI Advances Clinical Applications and Healthcare Software - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Bamco Inc. NY Increases Stake in Tempus AI, Inc. - National Today
Tempus AI, Inc. $TEM Shares Bought by Bamco Inc. NY - MarketBeat
Why Tempus AI, Inc. (TEM) Went Down On Wednesday - MSN
Cathie Wood buys $2 million of tumbling AI stock - MSN
Best Artificial Intelligence Stocks To Follow NowMarch 15th - MarketBeat
Clear Street Group Inc. Acquires Stake in Tempus AI - National Today
Casdin Capital LLC Purchases Shares of 294,127 Tempus AI, Inc. $TEM - MarketBeat
Clear Street Group Inc. Acquires Shares of 716,406 Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks Worth WatchingMarch 14th - MarketBeat
Tempus AI falls despite Q4 beats, 2026 revenue guidance above consensus - MSN
Tempus AI price target lowered to $80 from $85 at JPMorgan - MSN
Top Artificial Intelligence Stocks To Watch NowMarch 13th - MarketBeat
Tempus AI, Inc. $TEM Shares Acquired by Landscape Capital Management L.L.C. - MarketBeat
Tempus AI, Inc. Class A Trade Ideas — BX:TEM - TradingView
Tempus AI, Inc. $TEM Shares Acquired by BNP Paribas Financial Markets - MarketBeat
TEM Stock Price, Quote & Chart | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Assessing Tempus AI (TEM) Valuation As New Oncology Study Highlights Clinical Impact Of Its AI Platform - simplywall.st
Tempus AI Inc (TEM) Shares Down 5.14% on Mar 12 - GuruFocus
Tempus AI Expands Clinical Validation of AI-Powered Cancer Diagnostics - Yahoo Finance
First Trust Advisors LP Has $47.63 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Cathie Wood’s ARK sells LY Corp stock, buys Tempus AI - Investing.com
Tempus AI Broadens Clinical Assessment of AI-Driven Cancer Diagnostic Tools - Bitget
Promising Artificial Intelligence Stocks To Follow TodayMarch 11th - MarketBeat
Why Tempus AI Stock Is Up Wednesday?Tempus AI (NASDAQ:TEM) - Benzinga
Tempus cancer study: deeper test gives 1 in 8 new treatment options - Stock Titan
Tempus AI's (TEM) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Tempus AI: Underappreciated Oncology Platform and Data Business Poised for Reimbursement Upside and AI-Driven Growth - TipRanks
Tempus AI Earnings Call Highlights Strong Growth Path - TipRanks
Hims and Hers Expands Consumer-Focused Digital Health Platform - The Globe and Mail
Best Artificial Intelligence Stocks To Watch TodayMarch 10th - MarketBeat
H.C. Wainwright raises Tempus AI stock price target on partnerships - Investing.com
Does Merck–Tempus AI Oncology Partnership Reshape the Bull Case For Tempus AI (TEM)? - Sahm
Best Artificial Intelligence Stocks Worth WatchingMarch 9th - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Tempus AI Inc (TEM) Stock Price Down 3.2% on Mar 9 - GuruFocus
Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026? - The Globe and Mail
Should You Consider Purchasing, Retaining, or Selling Tempus AI Shares as 2026 Approaches? - Bitget
Assessing Tempus AI (TEM) Valuation After Expanded Merck Collaboration Announcement - Yahoo Finance
Tempus AI Deepens Merck Collaboration As Pharma Demand And Losses Evolve - Yahoo Finance
Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A Trade Ideas — BCBA:TEMD - TradingView
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):